Reuters logo
BRIEF-Sarepta Therapeutics prices $475 million of convertible senior notes due 2024
November 9, 2017 / 12:15 AM / a month ago

BRIEF-Sarepta Therapeutics prices $475 million of convertible senior notes due 2024

Nov 8 (Reuters) - Sarepta Therapeutics Inc

* Sarepta Therapeutics prices $475 million of convertible senior notes due 2024

* Sarepta Therapeutics-‍priced $475 million aggregate principal amount of convertible senior unsecured notes that will mature on November 15, 2024​

* Sarepta Therapeutics - ‍notes will bear cash interest at a rate of 1.50%, payable on May 15 and November 15 of each year, beginning on May 15, 2018​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below